Victória Machado Scheibe
Research Subjects
Research Interests
Victória Machado Scheibe has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Maria Schmidt
Brazilian Rare Disease Network, Porto Alegre, Brazil
3 shared publications - Milena Artifon
Exercise Research Laboratory, School of Physical Education, Physiotherapy and Dance, Universidade Federal do Grande do Sul, Porto Alegre, RS, Brazil
3 shared publications - Augusto Mädke Brenner
Centro de Pesquisa Clínica Hospital de Clínicas de Porto Alegre Porto Alegre RS Brazil Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
2 shared publications - Bibiana Mello de Oliveira
Federal University of Health Sciences of Porto Alegre (UFCSPA)
2 shared publications - Diego Bettiol Yamada
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
2 shared publications - Domingos Alves
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
2 shared publications
Latest Publications
- Open Access
- 27 July 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25, e44641
The Minimum Data Set for Rare Diseases: Systematic Review
Background: The minimum data set (MDS) is a collection of data elements to be grouped using a standard approach to allow the use of data for clinical and research purposes. Health data are typically voluminous, complex, and sometimes too ambiguous to generate indicators that can provide knowledge and information on health. This complexity extends further to the rare disease (RD) domain. MDSs are essential for health surveillance as they help provide services and generate recommended population indicators. There is a bottleneck in international literature that reveals a global problem with data collection, recording, and structuring in RD. Objective: This study aimed to identify and analyze the MDSs used for RD in health care networks worldwide and compare them with World Health Organization (WHO) guidelines. Methods: The population, concept, and context methodology proposed by the Joanna Briggs Institute was used to define the research question of this systematic review. A total of 4 databases were reviewed, and all the processes were reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. The data elements were analyzed, extracted, and organized into 10 categories according to WHO digital health guidelines. The quality assessment used the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. Results: We included 20 studies in our review, 70% (n=14) of which focused on a specific health domain and 30% (n=6) of which referred to RD in general. WHO recommends that health systems and networks use standard terminology to exchange data, information, knowledge, and intelligence in health. However, there was a lack of terminological standardization of the concepts in MDSs. Moreover, the selected studies did not follow the same standard structure for classifying the data from their MDSs. All studies presented MDSs with limitations or restrictions because they covered only a specific RD, or their scope of application was restricted to a specific context or geographic region. Data science methods and clinical experience were used to design, structure, and recommend a fundamental global MDS for RD patient records in health care networks. Conclusions: Our study highlights the difficulties in standardizing and categorizing findings from MDSs for RD because of the varying structures used in different studies. The fundamental RD MDS designed in this study comprehensively covers the data needs in the clinical and management sectors. These results can help public policy makers support other aspects of their policies. We highlight the potential of our results to help strategic decisions related to RD. Trial Registration: PROSPERO CRD42021221593; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221593 International Registered Report Identifier (IRRID): RR2-10.1016/j.procs.2021.12.034
- 27 July 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25, e44641
Open AccessThe Minimum Data Set for Rare Diseases: Systematic Review
Background: The minimum data set (MDS) is a collection of data elements to be grouped using a standard approach to allow the use of data for clinical and research purposes. Health data are typically voluminous, complex, and sometimes too ambiguous to generate indicators that can provide knowledge and information on health. This complexity extends further to the rare disease (RD) domain. MDSs are essential for health surveillance as they help provide services and generate recommended population indicators. There is a bottleneck in international literature that reveals a global problem with data collection, recording, and structuring in RD. Objective: This study aimed to identify and analyze the MDSs used for RD in health care networks worldwide and compare them with World Health Organization (WHO) guidelines. Methods: The population, concept, and context methodology proposed by the Joanna Briggs Institute was used to define the research question of this systematic review. A total of 4 databases were reviewed, and all the processes were reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. The data elements were analyzed, extracted, and organized into 10 categories according to WHO digital health guidelines. The quality assessment used the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. Results: We included 20 studies in our review, 70% (n=14) of which focused on a specific health domain and 30% (n=6) of which referred to RD in general. WHO recommends that health systems and networks use standard terminology to exchange data, information, knowledge, and intelligence in health. However, there was a lack of terminological standardization of the concepts in MDSs. Moreover, the selected studies did not follow the same standard structure for classifying the data from their MDSs. All studies presented MDSs with limitations or restrictions because they covered only a specific RD, or their scope of application was restricted to a specific context or geographic region. Data science methods and clinical experience were used to design, structure, and recommend a fundamental global MDS for RD patient records in health care networks. Conclusions: Our study highlights the difficulties in standardizing and categorizing findings from MDSs for RD because of the varying structures used in different studies. The fundamental RD MDS designed in this study comprehensively covers the data needs in the clinical and management sectors. These results can help public policy makers support other aspects of their policies. We highlight the potential of our results to help strategic decisions related to RD. Trial Registration: PROSPERO CRD42021221593; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221593 International Registered Report Identifier (IRRID): RR2-10.1016/j.procs.2021.12.034
- 28 February 2023
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 138 (3) , 87
LANDSCAPE OF INBORN ERRORS OF METABOLISM IN BRAZIL: DATA FROM THE BRAZILIAN RARE DISEASES NETWORK
- 28 February 2023
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 138 (3) , 87
LANDSCAPE OF INBORN ERRORS OF METABOLISM IN BRAZIL: DATA FROM THE BRAZILIAN RARE DISEASES NETWORK
- Open Access
- 1 January 2023
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 45
The Eysenck Personality Questionnaire Revised – Abbreviated (EPQR-A): psychometric properties of the Brazilian Portuguese version
The Eysenck Personality Questionnaire Revised – Abbreviated (EPQR-A) consists of 24 items for assessment of the three fundamental personality traits (psychoticism, extraversion, and neuroticism) and a validity scale (lie scale). Our objectives were to assess the psychometric properties of a version of this instrument culturally adapted for Brazil. 321 participants were recruited using a non-probabilistic method. Internal consistencies ranged from minimally acceptable to respectable, except for the psychoticism domain. Higher neuroticism scores were associated with higher depression and anxiety scores, higher extraversion scores were associated with lower levels of depression symptoms, and higher psychoticism scores were associated with higher levels of depression symptoms. Our findings describe sustainable psychometric properties for the Brazilian Portuguese version of EPQR-A.
- 1 January 2023
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 45
Open AccessThe Eysenck Personality Questionnaire Revised – Abbreviated (EPQR-A): psychometric properties of the Brazilian Portuguese version
The Eysenck Personality Questionnaire Revised – Abbreviated (EPQR-A) consists of 24 items for assessment of the three fundamental personality traits (psychoticism, extraversion, and neuroticism) and a validity scale (lie scale). Our objectives were to assess the psychometric properties of a version of this instrument culturally adapted for Brazil. 321 participants were recruited using a non-probabilistic method. Internal consistencies ranged from minimally acceptable to respectable, except for the psychoticism domain. Higher neuroticism scores were associated with higher depression and anxiety scores, higher extraversion scores were associated with lower levels of depression symptoms, and higher psychoticism scores were associated with higher levels of depression symptoms. Our findings describe sustainable psychometric properties for the Brazilian Portuguese version of EPQR-A.
- Open Access
- 15 December 2022
- Published by JMIR Publications Inc. in JMIR Preprints
The Minimum Data Set for Rare Diseases: Systematic Review (Preprint)
BACKGROUND The minimum data set (MDS) is a collection of data elements to be grouped using a standard approach to allow the use of data for clinical and research purposes. Health data are typically voluminous, complex, and sometimes too ambiguous to generate indicators that can provide knowledge and information on health. This complexity extends further to the rare disease (RD) domain. MDSs are essential for health surveillance as they help provide services and generate recommended population indicators. There is a bottleneck in international literature that reveals a global problem with data collection, recording, and structuring in RD. OBJECTIVE This study aimed to identify and analyze the MDSs used for RD in health care networks worldwide and compare them with World Health Organization (WHO) guidelines. METHODS The population, concept, and context methodology proposed by the Joanna Briggs Institute was used to define the research question of this systematic review. A total of 4 databases were reviewed, and all the processes were reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. The data elements were analyzed, extracted, and organized into 10 categories according to WHO digital health guidelines. The quality assessment used the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. RESULTS We included 20 studies in our review, 70% (n=14) of which focused on a specific health domain and 30% (n=6) of which referred to RD in general. WHO recommends that health systems and networks use standard terminology to exchange data, information, knowledge, and intelligence in health. However, there was a lack of terminological standardization of the concepts in MDSs. Moreover, the selected studies did not follow the same standard structure for classifying the data from their MDSs. All studies presented MDSs with limitations or restrictions because they covered only a specific RD, or their scope of application was restricted to a specific context or geographic region. Data science methods and clinical experience were used to design, structure, and recommend a fundamental global MDS for RD patient records in health care networks. CONCLUSIONS Our study highlights the difficulties in standardizing and categorizing findings from MDSs for RD because of the varying structures used in different studies. The fundamental RD MDS designed in this study comprehensively covers the data needs in the clinical and management sectors. These results can help public policy makers support other aspects of their policies. We highlight the potential of our results to help strategic decisions related to RD. CLINICALTRIAL PROSPERO CRD42021221593; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221593 INTERNATIONAL REGISTERED REPORT RR2-10.1016/j.procs.2021.12.034
- 15 December 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Minimum Data Set for Rare Diseases: Systematic Review (Preprint)
BACKGROUND The minimum data set (MDS) is a collection of data elements to be grouped using a standard approach to allow the use of data for clinical and research purposes. Health data are typically voluminous, complex, and sometimes too ambiguous to generate indicators that can provide knowledge and information on health. This complexity extends further to the rare disease (RD) domain. MDSs are essential for health surveillance as they help provide services and generate recommended population indicators. There is a bottleneck in international literature that reveals a global problem with data collection, recording, and structuring in RD. OBJECTIVE This study aimed to identify and analyze the MDSs used for RD in health care networks worldwide and compare them with World Health Organization (WHO) guidelines. METHODS The population, concept, and context methodology proposed by the Joanna Briggs Institute was used to define the research question of this systematic review. A total of 4 databases were reviewed, and all the processes were reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. The data elements were analyzed, extracted, and organized into 10 categories according to WHO digital health guidelines. The quality assessment used the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. RESULTS We included 20 studies in our review, 70% (n=14) of which focused on a specific health domain and 30% (n=6) of which referred to RD in general. WHO recommends that health systems and networks use standard terminology to exchange data, information, knowledge, and intelligence in health. However, there was a lack of terminological standardization of the concepts in MDSs. Moreover, the selected studies did not follow the same standard structure for classifying the data from their MDSs. All studies presented MDSs with limitations or restrictions because they covered only a specific RD, or their scope of application was restricted to a specific context or geographic region. Data science methods and clinical experience were used to design, structure, and recommend a fundamental global MDS for RD patient records in health care networks. CONCLUSIONS Our study highlights the difficulties in standardizing and categorizing findings from MDSs for RD because of the varying structures used in different studies. The fundamental RD MDS designed in this study comprehensively covers the data needs in the clinical and management sectors. These results can help public policy makers support other aspects of their policies. We highlight the potential of our results to help strategic decisions related to RD. CLINICALTRIAL PROSPERO CRD42021221593; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221593 INTERNATIONAL REGISTERED REPORT RR2-10.1016/j.procs.2021.12.034
- 19 August 2022
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 326, 111529
Structural magnetic resonance imaging findings in severe mental disorders adult inpatients: A systematic review
- 19 August 2022
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 326, 111529
Structural magnetic resonance imaging findings in severe mental disorders adult inpatients: A systematic review
- Open Access
- 12 September 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (12)
Benefícios do protocolo de manuseio mínimo em pacientes pré-termos extremos: percepção da equipe multiprofissional
O protocolo considera o princípio de Levine, a respeito da conservação de energia, integridade estrutural, pessoal e social, proporcionando suporte terapêutico com menos estresse para RNs de alto risco. A pesquisa objetiva conhecer a compreensão dos profissionais envolvidos na sistematização do Protocolo de Manuseio Mínimo (PMM) e investigar, no olhar da equipe, a influência do PMM na vida atual e a longo prazo no RN prematuro extremo durante a assistência, conhecer como é constituído o PMM na instituição e descrever os sentimentos dos profissionais quanto à capacitação para as boas práticas da realização adequada do método. Trata-se de uma pesquisa descritiva com abordagem qualitativa. Foi realizada com a equipe multiprofissional da Unidade de Terapia Intensiva Neonatal (UTIN), do Hospital Municipal de Canoas/RS. Os profissionais entrevistados foram médicos, fisioterapeutas, enfermeiros e profissionais formados em nível técnico de enfermagem que utilizaram em algum momento o PMM no RN extremo ou de alto risco. A coleta de dados deu-se através de uma entrevista semiestruturada com cinco perguntas abertas, que formaram as pré-categorias: constituição do PMM na instituição, benefícios a curto prazo e longo prazo, capacitação para a realização do manuseio mínimo. Os critérios de exclusão foram os profissionais desse hospital que recusaram-se a participar ou ausentavam-se. O principal benefício encontrado no trabalho foi a prevenção de hemorragia craniana através do PMM e do baixo estímulo foto, todavia evidenciou-se o indicie aquém do necessário de treinamentos da equipe. O presente trabalho foi aprovado pelo Comitê de Ética sob parecer nº 3.361.742 e CAAE 09495519.4.0000.5349.
- 12 September 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (12)
Open AccessBenefícios do protocolo de manuseio mínimo em pacientes pré-termos extremos: percepção da equipe multiprofissional
O protocolo considera o princípio de Levine, a respeito da conservação de energia, integridade estrutural, pessoal e social, proporcionando suporte terapêutico com menos estresse para RNs de alto risco. A pesquisa objetiva conhecer a compreensão dos profissionais envolvidos na sistematização do Protocolo de Manuseio Mínimo (PMM) e investigar, no olhar da equipe, a influência do PMM na vida atual e a longo prazo no RN prematuro extremo durante a assistência, conhecer como é constituído o PMM na instituição e descrever os sentimentos dos profissionais quanto à capacitação para as boas práticas da realização adequada do método. Trata-se de uma pesquisa descritiva com abordagem qualitativa. Foi realizada com a equipe multiprofissional da Unidade de Terapia Intensiva Neonatal (UTIN), do Hospital Municipal de Canoas/RS. Os profissionais entrevistados foram médicos, fisioterapeutas, enfermeiros e profissionais formados em nível técnico de enfermagem que utilizaram em algum momento o PMM no RN extremo ou de alto risco. A coleta de dados deu-se através de uma entrevista semiestruturada com cinco perguntas abertas, que formaram as pré-categorias: constituição do PMM na instituição, benefícios a curto prazo e longo prazo, capacitação para a realização do manuseio mínimo. Os critérios de exclusão foram os profissionais desse hospital que recusaram-se a participar ou ausentavam-se. O principal benefício encontrado no trabalho foi a prevenção de hemorragia craniana através do PMM e do baixo estímulo foto, todavia evidenciou-se o indicie aquém do necessário de treinamentos da equipe. O presente trabalho foi aprovado pelo Comitê de Ética sob parecer nº 3.361.742 e CAAE 09495519.4.0000.5349.
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 12
Fetal cyclophosphamide syndrome case report
- 1 October 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 97, 12
Fetal cyclophosphamide syndrome case report